Evidence map›Paper›PMID 27673578›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2016

A Synthesis of Exiguaquinol Dessulfate.

Gregg M Schwarzwalder, David R Scott, Christopher D Vanderwal

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gregg M SchwarzwalderDepartment of Chemistry, University of California, 1102 Natural Sciences II, Irvine, CA, 92697-2025, USA.
David R ScottDepartment of Physiology, UC Los Angeles/VA Greater Los Angeles Healthcare System, 11310 Wilshire Blvd, Bldg. 113, Rm. 324, Los Angeles, CA, 90073, USA.
Christopher D VanderwalDepartment of Chemistry, University of California, 1102 Natural Sciences II, Irvine, CA, 92697-2025, USA.ORCID http://orcid.org/0000-0001-7218-4521

Funding

Asymmetric Synthesis of Exiguaquinol and Analogs for Biological TestingF31CA180568 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI SCHWARZWALDER, GREGG · 2013 to 2015
$92k
NCI NIH HHS F31 CA180568
6 · The paper itself

Abstract

A concise and stereoselective synthesis of exiguaquinol dessulfate is described. Sequential application of a Diels-Alder cycloaddition, a desymmetrizing aldol addition, and a reductive Heck cyclization established most of the architecture of exiguaquinol, and a carefully choreographed introduction of the polar substituents afforded the title compound; unfortunately, naphthoquinol sulfation could not be achieved to deliver exiguaquinol. Our hypothesis regarding the configurational preference of the N-acyl hemiaminal, which was based upon an analysis of internal hydrogen-bonding interactions with polar functional groups, was proven correct. A late-stage intermediate did not demonstrate bactericidal activity against H. pylori cultures.

Indexed as

AldehydesCyclizationCycloaddition ReactionHydroquinonesMolecular Structure3-hydroxybutanalAldehydesexiguaquinolHydroquinonesantibioticsepimersHeck cyclizationnatural product synthesissulfation

Identifiers

PMID27673578
PMCPMC6028001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.